Itraconazole
- Product NDC
- 16729-271
- 11-digit product format
- 167290271
- Labeler code
- 16729
- Product ID
- 16729-271_ecb5f481-5b97-3973-e053-2995a90a9d04
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ITRACONAZOLE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Accord Healthcare Inc.
- Application
- ANDA205991
- Marketing category
- ANDA
- Marketing start
- 2017-05-30
- Marketing end
- 0000-00-00
- Substance
- ITRACONAZOLE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16729-271-10 | 16729027110 | 30 CAPSULE in 1 BOTTLE (16729-271-10) | 30 capsule | 2017-05-30 | 0000-00-00 | No | No | Current |